Figure S1. Microvesicles’ procoagulant potential.

Figure S2. correlation between tissue factor concentration and lag time.

Figure S3. Validation of the BD FACSCantoII flow cytometer using Megamix beads.

Figure S4. Representative example of flow cytometric microvesicle analysis in a sample.

Figure S5. Effect modification for type of diabetes.

Figure S6. Effect modification for statin use.

Figure S7. Effect modification for use of antiplatelet medication.

Table S1. Distribution of clinical parameters for the whole study population and reference ranges.

Data S1. Online data supplement.

JTH_4557_sm_FigS1-S7-TableS1.doc2136KSupporting info item

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.